SRSF2 and chronic myelomonocytic leukemia: Accordingly, CMML patient harboring CSF3R T618I mutation had a myeloproliferative phenotype with leukocytosis but showed concomitant dysplastic features, probably derived from the presence of double splicing-factor mutations, SRSF2 P95L and SF3B1 K666N.